How far we have come targeting BRAF-mutant non-small cell lung cancer (NSCLC).
Cancer Treat Rev
; 103: 102335, 2022 Feb.
Article
in En
| MEDLINE
| ID: mdl-35033867
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Proto-Oncogene Proteins B-raf
/
Molecular Targeted Therapy
/
Lung Neoplasms
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Cancer Treat Rev
Year:
2022
Document type:
Article
Country of publication: